LegalFix
Sign In

§ 516.22 - Permanent-resident U.S. agent for foreign sponsor.

Copy with citation
Copy as parenthetical citation

Every foreign sponsor that seeks MUMS-drug designation shall name a permanent resident of the United States as the sponsor's agent upon whom service of all processes, notices, orders, decisions, requirements, and other communications may be made on behalf of the sponsor. Notifications of changes in such agents or changes of address of agents should preferably be provided in advance, but not later than 60 days after the effective date of such changes. The permanent-resident U.S. agent may be an individual, firm, or domestic corporation and may represent any number of sponsors. The name and address of the permanent-resident U.S. agent shall be provided to the Director of the Office of Minor Use and Minor Species Animal Drug Development.

Previous Section
§ 516.21 - Documentation of minor use status.
Next Section
§ 516.23 - Timing of requests for MUMS-drug designation.